FDA/CDC

FDA backs Pfizer booster for 12- to 15-year-olds


 

Mixing and matching vaccines

Less clear at the moment is guidance about boosters for people who opted to mix and match their primary vaccine series.

“There was a mix-and-match study that was done which showed that in some cases, the mixing and matching … of an adenoviral record vaccine and an mRNA vaccine seem to give a very good immune response,” Dr. Marks said.

Once more data comes in on mixing and matching, “we’ll analyze them and then potentially make recommendations,” he said.

‘It’s not too late’

No federal government media briefing on COVID-19 would be complete without a plea for the unvaccinated to get immunized.

“We’re talking a lot about boosters right now, but it’s not too late for those who have not gotten a vaccine to get a vaccine,” Dr. Marks said, referring to the tens of millions of Americans who remain unvaccinated at the beginning of 2022.

“We know from our previous studies that even a single dose of the vaccine -- and probably two doses -- can help prevent the worst outcomes from COVID-19, including hospitalization and death.”

A version of this article first appeared on WebMD.com.

Pages

Recommended Reading

Does atopic dermatitis pose an increased risk of acquiring COVID-19?
MDedge Internal Medicine
COVID-19–associated ocular mucormycosis outbreak case study reveals high-risk group for deadly complication
MDedge Internal Medicine
Most cancer patients with breakthrough COVID-19 infection experience severe outcomes
MDedge Internal Medicine
Coronavirus can spread to heart, brain days after infection
MDedge Internal Medicine
NYC vaccine mandate for all businesses now in effect
MDedge Internal Medicine
COVID-19 antigen tests may be less sensitive to Omicron: FDA
MDedge Internal Medicine
COVID-19–positive or exposed? What to do next
MDedge Internal Medicine
Why patients should ditch cloth masks
MDedge Internal Medicine
Confusing messages on COVID taking a psychological toll
MDedge Internal Medicine
Travel/school disruptions as COVID-19 cases grow in 2022
MDedge Internal Medicine